Introduction to Novartis’ Breakthrough In a remarkable leap forward in cancer treatment, Novartis has made significant strides with its innovative approach to radioligand therapy. Dr. Michael Morris, an oncologist at Memorial Sloan Kettering Cancer Center in New York, described the results as “incredible.” In initial trials, imaging revealed no signs of cancer in approximately 9%…